20-F/A XBRL

20-F/A

Company: NewAmsterdam Pharma Co N.V.
Filed: October 28, 2024
Period of Report: December 31, 2022
Accession Number: 0000950170-24-117574

View Document ↗ View on SEC.gov ↗